NCT07144800 Family COMIDA (Consumo de Opciones Más Ideales De Alimentos) (Eating More Ideal Food Options)

Eligibility & Interventions

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 1,319 participants in total. It began in 2025-08-26 with a primary completion date of 2029-07-31.

Brief Summary

The purpose of this study is to determine the most effective family-centered intervention (FCI) for weight loss and obesity prevention in Hispanic families. FCI is a type of program that involves family (such as parents and caregivers) supporting their children to promote healthy habits.

Eligibility Criteria

Inclusion Criteria: Phase 1 * Age \>= 18 years (per self-report) * Self-identifies as Hispanic/Latino (per self-report) * Seeking, or has used, services at the VDS or MHU (per self-report) * Is the parent or primary caregiver for at least one child aged 8-12 living in their household (per self-report) * Screens as obese (BMI \> 30 kg/m2) or overweight (BMI of 25 - 29.9 kg/m2) (per height and weight measurement in person or per self-report) * Owns a cell phone capable of receiving text messages (per self-report) * Owns an internet connected device (e.g. cell phone, tablet, etc.) capable of conducting videoconference calls (per self-report) * Agrees to be audio-recorded (per self-report) Phase 2 (parent participants) * Age \>= 18 years (per self-report) * Self-identifies as Hispanic/Latino (per self-report) * Seeking, or has used, services at the VDS or MHU (per self-report) * Is the parent or primary caregiver for at least one child aged 8-12 living in their household (per self-report) * Screens as obese (BMI \> 30 kg/m2) or overweight (BMI of 25 - 29.9 kg/m2) (per height and weight measurement in person or remotely) * Owns a cell phone capable of receiving text messages (per self-report) * Owns an internet connected device (e.g. cell phone, tablet, etc.) capable of conducting videoconference calls (per self-report) * Agrees to be audio-recorded (per self-report) Phase 2 (child participants) * Age 8-12 years (per parent self-report) * Has a parent or primary caregiver who is eligible and participating in Phase 2 (per parent self-report) Exclusion Criteria: Phase 1 * Is pregnant or might be pregnant (per self-report) * Presence of a chronic disease such as cancer, kidney disease, liver disease, etc. (individuals with hypertension and diabetes mellitus may still participate) that may affect diet and study participation (per self-report) * Has dietary restrictions, i.e. liquid diet, that may affect diet and study participation (per self-report) * Has a household member who has already participated or agreed to participate in this study program (per self-report) * Prior participation in one of our preliminary studies, e.g., COMIDA, SANOS, Family COMIDA (per self-report) and any related focus groups * Works for or with the VDS or MHU (per self-report) * Presence of cognitive impairment disorder (i.e., delirium or dementia) sufficient to preclude meaningful informed consent and/or data collection (per study team) Phase 2 (parent participant) * Is pregnant or might be pregnant (per self-report) * For women, is lactating (per self-report) * Presence of a chronic disease such as cancer, kidney disease, liver disease, etc. (individuals with hypertension and diabetes mellitus may still participate) that may affect diet and study participation (per self-report) * Has dietary restrictions, i.e., liquid diet, that may affect diet and study participation (per self-report) * Has physical activity restrictions, i.e., handicapped or mobility issues, that may affect physical activity participation (increasing step counts; per self-report) * Has a household member who has already participated or agreed to participate in this study program (per self-report) * Prior participation in one of our preliminary studies, e.g., COMIDA, SANOS, Family COMIDA (per self-report) and any related focus groups * Works for or with the VDS or MHU (per self-report) * Presence of cognitive impairment disorder (i.e., delirium or dementia) sufficient to preclude meaningful informed consent and/or data collection (per study team) * Has been prescribed Ozempic, Wegovy, Mounjaro, Rybelsus, Trulicity (or other GLP 1 receptor agonist), or any other drug to treat obesity (per self-report) or (if previously prescribed) 7 weeks have not passed since the last dose was taken. * Has undergone weight loss/bariatric surgery (RYBG, gastric banding, sleeve gastrectomy, balloon, etc.) or is planning to undergo such surgery in the next 12 months (per self-report) Phase 2 (child participant) * Has dietary restrictions, i.e., liquid diet, that may affect diet and study participation (per parent self-report) * Has physical activity restrictions, i.e., handicapped or mobility issues, that may affect physical activity participation (per parent self-report) * Has an eating disorder (per parent self-report) * Is underweight (per parent self-report)

Contact & Investigator

Frequently Asked Questions

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.